Brainstorm Cell Therapeutics Inc. Soared

Tue, Nov 22, 2022 at 07:25 PM
Brainstorm Cell Therapeutics Inc. Soared

Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) soared at $1.95, a gain of 30%. The stock appeared on our News Catalysts scanner on Thu, Nov 17, 2022 at 12:14 PM in the 'BIOTECH' category. From Tue, Nov 08, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Mon, Aug 15, 2022 at $4.7 with a volume of 1M+.

About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.